pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Tag › imatinib

    Therapeutic dilemma in chronic myeloid leukemia: a clinical case with refractory and intolerant tyrosine kinase inhibitors

    Редактор | 2026, Clinical case, Practical medicine part 24 №3. 2026 | 5 июня, 2026

    U.A. YAKUBOVA1, 2, N.V. BUCHNEVA1, D.M. MIRMANOVA1  1Orenburg State Medical University, Orenburg 2Orenburg Regional Clinical Hospital named after V.I. Voynov, Orenburg Contact details: Yakubova U.A. — PhD (Medicine), Assistant Lecturer of the Department of Faculty Therapy and Endocrinology, hematologist Address: 6 Sovetskaya St., 460014 Orenburg, Russian Federation, tel.: +7-919-864-92-69, e-mail: yakubova.uliana@yandex.ru Currently, the leading treatment for […]

    Tag: 2026, asciminib, bosutinib, chronic myeloid leukemia, D.M. MIRMANOVA, dasatinib, imatinib, N.V. BUCHNEVA, nilotinib, Practical medicine part 24 №3. 2026, tyrosine kinase inhibitors, U.A. YAKUBOVA
    Комментарии к записи Therapeutic dilemma in chronic myeloid leukemia: a clinical case with refractory and intolerant tyrosine kinase inhibitors отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©